India bioeconomy growth stands at USD 165.7 billion based on the latest government data, driven by biotech startups, policy support, and manufacturing push, strengthening its role in economic expansion.
The Punjab government is rapidly improving Healthcare Scheme Access through the Mukh Mantri Sehat Yojna, with ASHA workers taking the lead in enrolments across the state.
Granules India Limited has announced that its wholly owned subsidiary, Granules Life Sciences (GLS), has received a Voluntary Action Indicated (VAI) classification from the US Food and Drug Administration (USFDA) following an inspectio...
Wockhardt has moved closer to market approval after its antibiotic Zaynich received a positive nod from the Central Drugs Standard Control Organization, marking a breakthrough in antibiotic space.
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its generic mental health drug — Paroxetine extended-release tablets, a medication commonly used to treat mental health conditions.
Alembic Pharmaceuticals Limited has secured USFDA approval for Paroxetine Extended-Release Tablets USP 12.5 mg, marking another step forward in its growing U.S. generics portfolio.
Eli Lilly’s eczema drug Ebglyss (lebrikizumab) is making waves with new long term data showing strong, lasting results for people with moderate to severe atopic dermatitis.
Chennai-based MGM Healthcare has set up what it says is the world’s largest intestinal rehabilitation programme and intestinal transplant programme in just three years, marking a significant step forward for advanced healthcare in India.
The U.S. Food and Drug Administration has approved a new oral treatment for psoriasis developed by Johnson & Johnson, offering patients a simpler and more convenient therapy option.
As India’s healthcare landscape evolves with cutting-edge diagnostic solutions, Chennai is set to witness a transformative development in Alzheimer’s screening.
, CDSCO.jpg)